p38α limits the contribution of MAP17 to cancer progression in breast tumors.
about
MAP17 and SGLT1 protein expression levels as prognostic markers for cervical tumor patient survival.Fibroblast growth factor 9 activates akt and MAPK pathways to stimulate steroidogenesis in mouse leydig cellsMAP17 (PDZKIP1) as a novel prognostic biomarker for laryngeal cancer.Efficacy of bortezomib in sarcomas with high levels of MAP17 (PDZK1IP1).Potential pathological and functional links between long noncoding RNAs and hematopoiesis.MAP17, a ROS-dependent oncogene.Elevation of MAP17 enhances the malignant behavior of cells via the Akt/mTOR pathway in hepatocellular carcinoma.Coordinated downregulation of Spinophilin and the catalytic subunits of PP1, PPP1CA/B/C, contributes to a worse prognosis in lung cancer.The cargo protein MAP17 (PDZK1IP1) regulates the immune microenvironment.EGFR-TKI resistance and MAP17 are associated with cancer stem cell like properties.Dr. Jekyll and Mr. Hyde: MAP17's up-regulation, a crosspoint in cancer and inflammatory diseases.MAP17 (PDZK1IP1) and pH2AX are potential predictive biomarkers for rectal cancer treatment efficacy
P2860
Q34589895-D78558F7-0477-43E1-92D2-7D0E08CC9350Q35113258-A209584D-3FED-42DA-B789-CF74192CBC5CQ35828640-21D52AA7-CB5E-4163-984B-0CB9C95DA429Q37687113-8F92070F-DED9-4C19-9596-62B17A24ED9EQ38130412-B9252B81-3FE7-4537-B399-9D8BF4F6DFB2Q42323237-5FFF8FBE-273F-48B9-85D6-DB8916260A4FQ46112391-BD756868-7F6E-4654-99EC-7186C36594D9Q47100472-73084767-DDA0-494A-A432-1A555A0B681FQ47122756-566B404C-EB4F-4362-B3D5-035992FD516FQ53698558-DCEAE17C-05A3-4F14-BE35-0CE2820D8836Q55227686-9D2B46DB-84F2-4002-AB0B-025118FABD5BQ58779402-93DAA709-E984-48E3-9869-5C32F92D6A28
P2860
p38α limits the contribution of MAP17 to cancer progression in breast tumors.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
p38α limits the contribution of MAP17 to cancer progression in breast tumors.
@en
p38α limits the contribution of MAP17 to cancer progression in breast tumors.
@nl
type
label
p38α limits the contribution of MAP17 to cancer progression in breast tumors.
@en
p38α limits the contribution of MAP17 to cancer progression in breast tumors.
@nl
prefLabel
p38α limits the contribution of MAP17 to cancer progression in breast tumors.
@en
p38α limits the contribution of MAP17 to cancer progression in breast tumors.
@nl
P2093
P2860
P50
P356
P1433
P1476
p38α limits the contribution of MAP17 to cancer progression in breast tumors.
@en
P2093
M V Guijarro
S Muñoz-Galván
S Ramon y Cajal
P2860
P2888
P304
P356
10.1038/ONC.2011.619
P407
P577
2012-01-23T00:00:00Z
P6179
1014389966